Concepedia

A Ablin

AA

6

Publications

695

Citations

6

H-Index

1984

Active since

Affiliations

University of California, San Francisco(Current)

A Ablin is an author at University of California, San Francisco specializing in medicine, hematology, and anatomy.

Top concepts

Publications per year

1984–1998

6

Publications

6

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma.

Katherine K. Matthay, Kenneth B. DeSantes, B.H. Hasegawa et al. · Journal of Clinical Oncology · 1998 · 217 citations

Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco.

B Willis, A Ablin, V. Weinberg et al. · Journal of Clinical Oncology · 1996 · 160 citations

Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106.

Paul S. Gaynon, Peter G. Steinherz, W. Archie Bleyer et al. · Journal of Clinical Oncology · 1993 · 131 citations

INTENSIVE THERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA AND UNFAVOURABLE PRESENTING FEATURES

PaulS. Gaynon, W. Archie Bleyer, VincentC. Albo et al. · The Lancet · 1988 · 117 citations

, , +5

Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma.

K. K. Matthay, J P Huberty, Robert S. Hattner et al. · PubMed · 1992 · 51 citations

, , +16

Rows per page

1–5 of 6